Carcinoma, Lobular
Showing 26 - 50 of 7,866
Breast Cancer Female, Stage I Breast Cancer, Stage II Breast Cancer Trial in Austin (Breast reconstruction decision aid,
Completed
- Breast Cancer Female
- +6 more
- Breast reconstruction decision aid
- Educational website
-
Austin, TexasTexas Oncology
Nov 1, 2021
Inflammatory Breast Cancer, Invasive Ductal Breast Carcinoma, Invasive Lobular Breast Carcinoma Trial in New Brunswick, Salt
Active, not recruiting
- Inflammatory Breast Cancer
- +9 more
- External beam radiation therapy
-
New Brunswick, New Jersey
- +1 more
Jan 30, 2022
Lobular Breast Carcinoma, Gastric Cancer, Triple Negative Breast Cancer Trial in United Kingdom (Crizotinib Oral Capsule
Recruiting
- Lobular Breast Carcinoma
- +3 more
- Crizotinib Oral Capsule [Xalkori]
- Fulvestrant 50 MG/ML Prefilled Syringe [Faslodex or generic]
-
Glasgow, United Kingdom
- +7 more
Nov 1, 2021
Atypical Hyperplasia of the Breast, Lobular Breast Carcinoma In Situ, Pleomorphic Lobular Breast Carcinoma In Situ Trial in
Recruiting
- Atypical Hyperplasia of the Breast
- +2 more
- Cancer Educational Materials
- +3 more
-
Costa Mesa, California
- +48 more
Jan 9, 2023
Breast Carcinoma, Breast Ductal Carcinoma In Situ, Breast Lobular Carcinoma In Situ Trial in Columbus (EMBr Wave, Questionnaire
Recruiting
- Breast Carcinoma
- +3 more
- EMBr Wave
- Questionnaire Administration
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Oct 20, 2021
BRCA1 Mutation Carrier, BRCA2 Mutation Carrier, Ductal Breast Carcinoma in Situ Trial in Los Angeles (dietary supplement, other,
Active, not recruiting
- BRCA1 Mutation Carrier
- +8 more
- soy isoflavones
- +7 more
-
Los Angeles, CaliforniaUniversity of Southern California
Nov 11, 2021
Breast Ductal Carcinoma In Situ, Breast Lobular Carcinoma In Situ, Stage 0 Breast Cancer AJCC v6 and v7 Trial in Los Angeles,
Active, not recruiting
- Breast Ductal Carcinoma In Situ
- +12 more
- Endoxifen Hydrochloride
- +2 more
-
Los Angeles, California
- +2 more
Mar 8, 2022
Benign Breast Tumor, Ductal Breast Carcinoma In Situ, Invasive Breast Carcinoma Trial in Boston, New York, Houston
Completed
- Benign Breast Neoplasm
- +11 more
- Docosahexaenoic Acid
- Placebo
-
Boston, Massachusetts
- +3 more
Dec 3, 2021
DCIS Grade 3, Stage I Breast Cancer, Stage II Breast Cancer Trial in Oslo, Trondheim (Intervention. Exercise)
Active, not recruiting
- DCIS Grade 3
- +3 more
- Intervention. Exercise
-
Oslo, Norway
- +1 more
Apr 23, 2021
Invasive Ductal and Invasive Lobular Breast Carcinoma, Stage 0 Breast Carcinoma, Stage I Breast Carcinoma Trial in Orange
Active, not recruiting
- Invasive Ductal and Invasive Lobular Breast Carcinoma
- +3 more
- Intraoperative Radiotherapy
-
Orange, CaliforniaSt. Joseph Hospital of Orange
Mar 30, 2021
Invasive Ductal Carcinoma, Invasive Lobular Carcinoma, Ductal Carcinoma Trial in Philadelphia (Indocyanine Green)
Completed
- Invasive Ductal Carcinoma
- +2 more
- Indocyanine Green
-
Philadelphia, PennsylvaniaHospital of the University of Pennsylvania
Jan 26, 2021
Ductal Breast Carcinoma in Situ, Invasive Ductal Breast Carcinoma, Invasive Lobular Breast Carcinoma Trial in Philadelphia
Completed
- Ductal Breast Carcinoma in Situ
- +6 more
- Behavioral dietary intervention
- +4 more
-
Philadelphia, PennsylvaniaThomas Jefferson University
Dec 4, 2019
Ductal Breast Carcinoma, Ductal Breast Carcinoma In Situ, Estrogen Receptor Negative Trial in Buffalo (Broccoli Sprout Extract,
Completed
- Ductal Breast Carcinoma
- +10 more
- Broccoli Sprout Extract
- +3 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Oct 29, 2019
High-Risk Breast Duct Epithelium
Completed
- Breast Cancer
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 8, 2023
Ductal Breast Carcinoma in Situ, Lobular Breast Carcinoma in Situ, Male Breast Cancer Trial in Winston-Salem (omega-3 fatty
Completed
- Ductal Breast Carcinoma in Situ
- +8 more
- omega-3 fatty acid
- +2 more
-
Winston-Salem, North CarolinaComprehensive Cancer Center of Wake Forest University
Oct 7, 2019
Breast Carcinoma, Ductal Breast Carcinoma In Situ, Hot Flashes Trial in United States (Oxybutynin Chloride, Placebo,
Completed
- Breast Carcinoma
- +4 more
- Oxybutynin Chloride
- +3 more
-
Peoria, Illinois
- +12 more
Jan 14, 2020
Predict Neoadjuvant Chemotherapy Response in Breast Cancer
Active, not recruiting
- Breast Cancer
- +2 more
- Radiomic, pathomic, and clinical markers
-
Toronto, Ontario, CanadaSunnybrook Health Sciences Centre
Jul 12, 2019
Atypical Ductal Breast Hyperplasia, BRCA1 Gene Mutation, BRCA2 Gene Mutation Trial in Columbus (curcumin, Biomarker analysis,
Completed
- Atypical Ductal Breast Hyperplasia
- +4 more
- curcumin
- +3 more
-
Columbus, OhioArthur G. James Cancer Hospital and Solove Research Institute at
Aug 29, 2019
BRCA1 Mutation Carrier, BRCA2 Mutation Carrier, Ductal Breast Carcinoma In Situ Trial in West Hollywood, Chicago, New York
Unknown status
- BRCA1 Mutation Carrier
- +8 more
- Telapristone Acetate
- +3 more
-
West Hollywood, California
- +2 more
Aug 16, 2019
Megakaryocytes and Platelets in Breast Cancer
Not yet recruiting
- Breast Cancer
- Blood draw
- (no location specified)
Aug 21, 2023
Blood and Tumor Tissue Samples in Invasive Breast Cancer, Ductal
Completed
- Breast Cancer
- gene expression analysis
- +10 more
-
Beverly Hills, California
- +2 more
Dec 23, 2019
Sleep Apnoea Syndrome and Hepatocellular Carcinoma
Withdrawn
- Sleep Apnea, Obstructive
- +2 more
- Nocturnal oximetry
-
La Tronche, Rhones-Alpes, FranceMinovés-Kotzki
May 17, 2022